Based on the correlation between our computational results and previous experimental observations, our study provides insights to cope with the ASM resistance in refractory epilepsies by manipulation of the hydrophobic interactions between the pharmaceutical compound and both P-gp and membrane lipids. This evidence concerns the gene PGP and epilepsy.